We are live on ! Find out more
RAIN

Rain Oncology Inc. Common Stock
RAIN

Delisted

RAIN was delisted on the 25th of January, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in Rain Oncology Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 58 → 0 (-58)

100% less capital invested

Capital invested by funds: $20.4M → $0 (-$20.4M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 58

Holders
–
Holders Change
-58
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
58
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
-$4.62M
2
BI
BVF Inc
California
-$4.23M
3
SB
Samsara BioCapital
California
-$2.44M
4
BCM
BML Capital Management
Indiana
-$1.62M
5
BC
Boxer Capital
California
-$1.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
1
Tang Capital Management
California
– -$4.62M -3,850,513 Closed
BI
2
BVF Inc
California
– -$4.23M -3,526,729 Closed
SB
3
Samsara BioCapital
California
– -$2.44M -2,034,552 Closed
BCM
4
BML Capital Management
Indiana
– -$1.62M -1,349,007 Closed
BC
5
Boxer Capital
California
– -$1.38M -1,152,212 Closed
BlackRock
6
BlackRock
New York
– -$1.31M -1,090,707 Closed
Vanguard Group
7
Vanguard Group
Pennsylvania
– -$1.05M -872,459 Closed
AI
8
Acuitas Investments
Washington
– -$539K -410,464 Closed
DAM
9
Deltec Asset Management
New York
– -$449K -373,978 Closed
Geode Capital Management
10
Geode Capital Management
Massachusetts
– -$397K -331,059 Closed
State Street
11
State Street
Massachusetts
– -$274K -228,121 Closed
ETC
12
Exchange Traded Concepts
Oklahoma
– -$205K -170,554 Closed
Two Sigma Advisers
13
Two Sigma Advisers
New York
– -$189K -157,100 Closed
Northern Trust
14
Northern Trust
Illinois
– -$139K -115,856 Closed
Two Sigma Investments
15
Two Sigma Investments
New York
– -$132K -110,347 Closed
MAM
16
Marquette Asset Management
Minnesota
– -$122K -101,523 Closed
SO
17
STRS Ohio
Ohio
– -$120K -100,100 Closed
Morgan Stanley
18
Morgan Stanley
New York
– -$112K -93,054 Closed
BCM
19
Bridgeway Capital Management
Texas
– -$97.8K -81,500 Closed
Susquehanna International Group
20
Susquehanna International Group
Pennsylvania
– -$80.3K -66,941 Closed
GS
21
GTS Securities
New York
– -$60K -50,017 Closed
Jane Street
22
Jane Street
New York
– -$54.3K -45,212 Closed
AllianceBernstein
23
AllianceBernstein
Tennessee
– -$51.1K -42,580 Closed
Bank of New York Mellon
24
Bank of New York Mellon
New York
– -$50.2K -41,801 Closed
Charles Schwab
25
Charles Schwab
California
– -$46.6K -38,822 Closed
1
2 3

RAIN Hedge Fund Activity: Q1 2024 in Review

0 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Rain Oncology Inc. Common Stock (RAIN) for Q1 2024, worth a combined $0 — down 100% from $20.4M a quarter earlier.

Sellers outnumbered buyers: 58 funds closed out of RAIN and 0 opened new positions — a net loss of 58 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Tang Capital Management, exiting entirely with an estimated $4.62M sold.

  • 0 institutional investors held Rain Oncology Inc. Common Stock (RAIN) as of Q1 2024, down from 58 in Q4 2023.
  • Funds reported $0 of Rain Oncology Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Rain Oncology Inc. Common Stock positions in Q1 2024 and 58 closed out, a net change of -58 holders.
  • The largest Rain Oncology Inc. Common Stock seller in Q1 2024 was Tang Capital Management, an estimated $4.62M sold.

Based on aggregated 13F filings for Q1 2024.